Kolexia
Duhamel Elisabeth
Médecine interne
Centre Hospitalier de Saint Brieuc
Saint-Brieuc, France
26 Activités
1 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thromboembolie Thromboembolisme veineux Embolie Embolie pulmonaire Thrombose veineuse Hémorragie Thrombose Sténose de la veine pulmonaire Érythème noueux

Industries

B3TSI
1 collaboration(s)
Dernière en 2020
Bayer
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study.
PLoS neglected tropical diseases   20 avril 2023
Padis-Ext: Six Years of Follow-up After Extended Duration of Oral Anticoagulant Therapy for a First Episode of Idiopathic Pulmonary Embolism or Proximal Deep Vein Thrombosis.
Essai Clinique (CHU Brest)   17 octobre 2022
Six months two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.
Haematologica   03 janvier 2019
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.
The European respiratory journal   04 janvier 2018
PADIS TVP: Eighteen Months of Oral Anticoagulant Therapy Versus Placebo After 6 Six Months of Anticoagulation for a First Episode of Idiopathic Proximal Deep Vein Thrombosis: a Multicentre Double-Blind Randomized Controlled Trial. "PADIS-TVP" Study.
Essai Clinique (CHU Brest)   11 janvier 2017
PADIS EP: Eighteen Months of Oral Anticoagulant Therapy Versus Placebo After 6 Six Months of Anticoagulation for a First Episode of Idiopathic Pulmonary Embolism: a Multicentre Double-blind Randomized Controlled Trial. "PADIS-PE" Study.
Essai Clinique (CHU Brest)   11 janvier 2017
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
JAMA   23 juillet 2015
Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Leukemia & lymphoma   21 janvier 2015
Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial
Blood   14 novembre 2014
Fever and erythema nodosa in a 33-year-old woman.
La Revue de medecine interne   12 juillet 2012